11C-T-1650

N/A

Report date: 2026/03/12 20:00:16
NME

Base Information

Drug Name11C-T-1650
Drug Alias Name11C-T-1650
ClassificationRadiation-emitting productsSmall molecules > Heterocyclic drugs
Mechanisms of ActioncAMP-specific 3',5'-cyclic phosphodiesterase 4D inhibitors
TargetscAMP-specific 3',5'-cyclic phosphodiesterase 4D
Therapy Area/IndicationsDepressionBrain Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTetra Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesTetra Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsDepressionBrain Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A